Browse All Conditions

Explore 28,708 medical conditions with active and completed U.S. clinical trial data drawn from ClinicalTrials.gov. According to ClinicalTrials.gov, the NIH registry maintained by the National Library of Medicine contains more than 500,000 studies in more than 220 countries. The 2007 FDAAA requires registration for most FDA-regulated studies. See our methodology for refresh cadence.

PlainTrial's condition directory indexes every disease, disorder, syndrome, and medical condition with at least one clinical study registered on ClinicalTrials.gov. Each entry links to a per-condition profile page showing recruiting trials, completed studies, phase distribution, sponsor mix, and geographic coverage. We use the MeSH-aligned condition names submitted by trial sponsors to the National Library of Medicine, so a condition you find here is the same condition a clinician would search on PubMed or a researcher would tag in a grant application.

Use the alphabetical index to browse the full list, or sort by trial volume to find conditions with the deepest active research pipelines. Conditions with a "Recruiting" count in the third column have at least one trial currently enrolling participants - click through to see locations and eligibility. Conditions with high trial counts but zero recruiting slots usually reflect a maturing pipeline (Phase 3 studies are enrollment-closed) or a condition where standard-of-care has shifted research focus to combination therapies and post-approval surveillance.

The directory is comprehensive but not equally deep across conditions. Rare diseases may show fewer than a handful of trials because patient populations are limited - this is a feature of clinical research, not an indexing gap on our end. Common conditions (cancer subtypes, diabetes, hypertension, depression) show dozens to hundreds of studies because they attract the broadest sponsor investment. Every number on this page comes directly from ClinicalTrials.gov; we do not manually edit counts, and we update from the NLM bulk-export on a regular cadence so what you see reflects the most recent registry state we have ingested.

Breast Cancer1,251Healthy1,096Obesity1,057Prostate Cancer749Depression687Cancer621HIV Infections615Hypertension472Stroke456Non-Small Cell Lung Cancer455
A2,809B1,091C2,928D1,168E986F825G765H1,701I1,106J82K187L1,231M2,114N1,012O820P2,801Q24R1,691S3,009T967U528V509W238X47Y19Z17
Treemap Treemap of 10 categories, sized proportional to value. Breast Cancer 1,251 Healthy 1,096 Obesity 1,057 Prostate Cancer 749 Depression 687 Cancer 621 HIV Infections 615 Hypertension 472 Stroke 456 Non-Small Cell Lu… 455

† Condition counts include only the 60,823 of 175,638 indexed trials (35%) that have a condition list: 92% of recruiting and active trials but 24% of completed ones, so completed and closed studies are under-counted. How the counts are built

Condition Trials†
Refractory Lung Small Cell Carcinoma 1
Refractory Lupus Nephritis 1
Refractory Lymphoma 40
Refractory Lymphoplasmacytic Lymphoma 1
Refractory Malignant Brain Neoplasm 1
Refractory Malignant Female Reproductive System Neoplasm 1
Refractory Malignant Glioma 2
Refractory Malignant Neoplasm 5
Refractory Malignant Solid Neoplasm 60
Refractory Mantle Cell Lymphoma 13
Refractory Mantle Cell Lymphoma (MCL) 1
Refractory Marginal Zone Lymphoma 3
Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma 1
Refractory Medulloblastoma 2
Refractory Melanoma 4
Refractory Merkel Cell Carcinoma 1
Refractory Metastatic Colorectal Cancer 2
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1
Refractory Microsatellite Stable Colorectal Carcinoma 1
Refractory Mixed Lineage Leukemia 1
Refractory Mixed Phenotype Acute Leukemia 3
Refractory Mixed Type Melasma 1
Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder 2
Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy 1
Refractory Multiple Myeloma 68
Refractory Myasthenia Gravis 1
Refractory Mycosis Fungoides 4
Refractory Myelodysplastic Syndrome 14
Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia 2
Refractory Myelodysplastic Syndromes 3
Refractory Myelodysplastic/Myeloproliferative Neoplasm 3
Refractory Myeloproliferative Neoplasm 1
Refractory Neoplasm 1
Refractory Nervous System Lymphoma 1
Refractory Neuroblastoma 10
Refractory Neurofibromatosis Type 1 1
Refractory Nodular Lymphocyte Predominant B-Cell Lymphoma 1
Refractory Non-Hodgkin Lymphoma 18
Refractory Non-Small Cell Lung Cancer 1
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1
Refractory or Unexplained Chronic Cough 1
Refractory Osteosarcoma 8
Refractory Ovarian Carcinoma 3
Refractory Pancreatic Adenocarcinoma 1
Refractory Pancreatic Carcinoma 3
Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified 2
Refractory Plasma Cell Myeloma 26
Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder 2
Refractory Primary Amyloidosis 1
Refractory Primary Central Nervous System Lymphoma 3